Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Recruiting × Tamsulosin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Urinary Retention 1 Lung Neoplasms 1

Interventions

pembrolizumab 99 Cyclophosphamide 72 Carboplatin 56 fludarabine 52 Injections 52 Bevacizumab 46 Gemcitabine 38 Nivolumab 36 venetoclax 35 Paclitaxel 34 Dexamethasone 34 Cisplatin 34 Specimen Handling 33 Magnetic Resonance Spectroscopy 31 Docetaxel 31 Biopsy 29 Temozolomide 25 atezolizumab 24 Irinotecan 23 toripalimab 22 Pemetrexed 22 Capecitabine 21 Azacitidine 21 abemaciclib 20 Rituximab 20 Oxaliplatin 20 Fulvestrant 20 Radiotherapy 19 Fluorouracil 19 130-nm albumin-bound paclitaxel 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03609580 2025-10-24

POUR

Hackensack Meridian Health

Phase 1/2 Recruiting

Lung Neoplasms, Urinary Retention

Data powered by HemOnc (CC BY 4.0) Colophon ⚡